Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimeric-001 (M-001) Prime-Boost with TIV in Elderly
NCT01419925Phase 2Completed
- Sponsor
- Scinai Immunotherapeutics Ltd.
- Start
- Aug 2011
- Primary completion
- Jan 2012
- Modality
- Peptides, Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of multimeric-001 in influenza, sponsored by Scinai Immunotherapeutics Ltd.. Started Aug 2011; status: completed.
02
Drugs
multimeric-001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01419925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419925.